Browse > Article
http://dx.doi.org/10.3857/jkstro.2008.26.3.142

Results of Breast Conserving Surgery and Subsequent Postoperative Radiotherapy for Cases of Breast Cancer  

Chie, Eui-Kyu (Department of Radiation Oncology, Seoul National University College of Medicine)
Kim, Kyu-Bo (Department of Radiation Oncology, Seoul National University College of Medicine)
Choi, Jin-Hwa (Department of Radiation Oncology, Seoul National University College of Medicine)
Jang, Na-Young (Department of Radiation Oncology, Seoul National University College of Medicine)
Han, Won-Shik (Department of Surgery, Seoul National University College of Medicine)
Noh, Dong-Young (Department of Surgery, Seoul National University College of Medicine)
Im, Seock-Ah (Department of Internal Medicine, Seoul National University College of Medicine)
Kim, Tae-You (Department of Internal Medicine, Seoul National University College of Medicine)
Bang, Yung-Jue (Department of Internal Medicine, Seoul National University College of Medicine)
Ha, Sung-Whan (Department of Radiation Oncology, Seoul National University College of Medicine)
Publication Information
Radiation Oncology Journal / v.26, no.3, 2008 , pp. 142-148 More about this Journal
Abstract
Purpose: We analyzed the treatment outcomes and prognostic factors of breast conserving surgery, followed by postoperative radiotherapy.Materials and Methods: A total of 424 breast cancer patients treated with breast conserving surgery and postoperative radiotherapy between February 1992 and January 2001 were retrospectively analyzed. A quadrantectomy and axillary lymph node dissection was performed in 396 patients. A total of 302 patients had T1 disease, and 122 patients had T2 disease. Lymph node involvement was confirmed in 107 patients. Whole breast irradiation was administered at up to 50.4 Gy in 28 fractions, followed by a 10 Gy boost in 5 fractions to the tumor bed. In addition, 57 patients underwent regional lymph node irradiation. Moreover, chemotherapy was administered in 231 patients. A regimen consisting of cyclophosphamide, methotrexate, and 5-fluorouracil was most frequently used with 170 patients. The median follow-up time was 64 months. Results: The 5-year local control rate was 95.6%. During the follow-up period, local tumor recurrence was observed in 15 patients. The 5-year overall and disease-free survival rates were 93.1% and 88.7%, respectively. The 5-year overall survival rates, by stage, were 94.8% for stage I, 95.0% for stage IIA, 91.1% for stage IIB, 75.9% for stage IIIA, and 57.1% for stage IIIC. As for disease-free survival, the corresponding figures, by stage (in the same order), were 93.1%, 89.4%, 82.8%, 62.0%, and 28.6%, respectively. The advanced N stage (p=0.0483) was found to be a significant prognostic factor in predicting poor overall survival, while the N stage (p=0.0284) and age at diagnosis (p=0.0001) were associated with disease-free survival. Conclusion: This study has shown that breast conserving surgery and postoperative radiotherapy for early breast cancer results was excellent for local control and survival.
Keywords
Breast cancer; Breast conserving surgery; Radiotherapy;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996;14:1558-1564   DOI   PUBMED
2 Koh KW, Kim MS, Yoo SY, et al. The results of primary radiotherapy following breast-conserving surgery for early breast cancer. J Korean Soc Ther Radiol Oncol 1995;13: 163-171
3 Kim JH, Kim OB, Kim YS. Breast conserving operation and radiation therapy in early breast cancer: interim analysis. J Korean Soc Ther Radiol Oncol 2001;19:27-33
4 American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual. 6th ed. New York; Springer-Verlag, 2002: 223-240
5 Veronesi U, Volterrani F, Luini A, et al. Quadrantectomy vs. lumpectomy for small size breast cancer. Eur J Cancer 1990;26:671-673   DOI   ScienceOn
6 Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005;16:1569-1583   DOI   ScienceOn
7 Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004;351:963-970   DOI   ScienceOn
8 Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001;30:96-102   PUBMED
9 Kim YS, Yoon SC, Chung SM, Ryu MR, Jung SS, Choi IB. Breast conservation therapy versus mastectomy: preliminary results of pattern of failure and survival rate in early breast cancer. J Korean Soc Ther Radiol Oncol 2004;22:115-123
10 Hughes K, Schnaper L, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971-977   DOI   ScienceOn
11 Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000;18:1688-1675
12 Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-1232   DOI   ScienceOn
13 Zhou P, Recht A. Young age and outcome for women with early-stage invasive breast carcinoma. Cancer 2004;101:1264-1274   DOI   ScienceOn
14 Fisher B, Anderson S, Bryant J, et al. Twenty-year followup of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241   DOI   ScienceOn
15 Joslyn SA. Geographic differences in treatment of early stage breast cancer. Breast J 1999;5:29-35   DOI   ScienceOn
16 Lee MZ, Chun HC. Radiation therapy for operable breast cancer after conservative surgery. J Korean Soc Ther Radiol Oncol 2004;20:309-315
17 Ahn SH, Yoo KY. The Korean Breast Cancer Society. Chronological changes of clinical characteristics in 31115 new breast cancer patients among Koreans during 1996-2004. Breast Cancer Res Treat 2006;99:209-214   DOI
18 Kim KJ, Huh SJ, Yang JH, et al. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Jpn J Clin Oncol 2005;35:126-133   DOI   ScienceOn
19 Nattinger AB, Kneusel RT, Hoffmann RG, et al. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst 2001;93:1344-1346   DOI   ScienceOn
20 Hankey BF, Miller B, Curtis R, Kosary C. Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst Monogr 1994;16:7-14   PUBMED
21 Lee SH, Lee KC, Choi J, et al. Radiation therapy and chemotherapy after breast conserving surgery for invasive breast cancer: an intermediate result. J Korean Soc Ther Radiol Oncol 2007;25:16-25   과학기술학회마을
22 Bartelink H, van Dam F, can Dongen J. Psychological effects of breast conserving therapy in comparison with radical mastectomy. Int J Radiat Oncol Biol Phys 1985;11:381-385   DOI   ScienceOn
23 van Dongen JA, Voogd AC, Fentiman IS, et al. Longterm results of a randomized trial comparing breastconserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000;92:1143-1150   DOI   ScienceOn
24 Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. Oncologist 2004;9:606-616   DOI   ScienceOn
25 van der Hage JA, van der Velde CJH, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001;19:4224-4237   DOI
26 Poggi MM, Danforth DN, Sciuto LC, et al. Eighteenyear results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003;98:697-702   DOI   ScienceOn
27 Leong C, Boyages J, Jayasinghe UW, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 2004;100:1823-1832   DOI   ScienceOn
28 Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346   DOI   ScienceOn
29 National Institutes of Health Consensus Development Panel. Consensus statement: Treatment of early-stage breast cancer. J Natl Cancer Inst Monogr 1992;11:1-5   PUBMED
30 Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. J Natl Cancer Inst Monogr 1992;11:19-25   PUBMED
31 Suh CO, Chung EJ, Lee HD, Lee KS, Oh KK, Kim GE. Risk factors for recurrence after conservative treatment in early breast cancer: preliminary report. J Korean Soc Ther Radiol Oncol 1994;12:337-347   과학기술학회마을
32 Solin LJ, Fowbie B, Schultz DJ, Goodman RL. Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phy 1989;16:373-381   DOI   ScienceOn
33 Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005;366:2087-2106   DOI   PUBMED
34 Ministry of Health and Welfare. 2002 Annual Report of the Korea Central Cancer Registry (Published in 2003)
35 Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999;44:1005-1015   DOI   ScienceOn
36 Nixon AJ, Neuberg D, Hayes DF, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994;12:888-894   DOI
37 Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001;12:997-1003   DOI   ScienceOn